135 related articles for article (PubMed ID: 35960817)
1. Immunodeficiency, autoimmunity, and increased risk of B cell malignancy in humans with
Rae W; Sowerby JM; Verhoeven D; Youssef M; Kotagiri P; Savinykh N; Coomber EL; Boneparth A; Chan A; Gong C; Jansen MH; du Long R; Santilli G; Simeoni I; Stephens J; Wu K; Zinicola M; Allen HL; Baxendale H; Kumararatne D; Gkrania-Klotsas E; Scheffler Mendoza SC; Yamazaki-Nakashimada MA; Ruiz LB; Rojas-Maruri CM; Lugo Reyes SO; Lyons PA; Williams AP; Hodson DJ; Bishop GA; Thrasher AJ; Thomas DC; Murphy MP; Vyse TJ; Milner JD; Kuijpers TW; Smith KGC
Sci Immunol; 2022 Aug; 7(74):eabn3800. PubMed ID: 35960817
[TBL] [Abstract][Full Text] [Related]
2. Lymphocyte-specific TRAF3 transgenic mice have enhanced humoral responses and develop plasmacytosis, autoimmunity, inflammation, and cancer.
Zapata JM; Llobet D; Krajewska M; Lefebvre S; Kress CL; Reed JC
Blood; 2009 May; 113(19):4595-603. PubMed ID: 19074733
[TBL] [Abstract][Full Text] [Related]
3. TNF receptor-associated factor 3 restrains B-cell receptor signaling in normal and malignant B cells.
Whillock AL; Ybarra TK; Bishop GA
J Biol Chem; 2021; 296():100465. PubMed ID: 33639170
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor receptor-associated factor 3 is a critical regulator of B cell homeostasis in secondary lymphoid organs.
Xie P; Stunz LL; Larison KD; Yang B; Bishop GA
Immunity; 2007 Aug; 27(2):253-67. PubMed ID: 17723217
[TBL] [Abstract][Full Text] [Related]
5. Genetic inactivation of TRAF3 in canine and human B-cell lymphoma.
Bushell KR; Kim Y; Chan FC; Ben-Neriah S; Jenks A; Alcaide M; Fornika D; Grande BM; Arthur S; Gascoyne RD; Steidl C; Morin RD
Blood; 2015 Feb; 125(6):999-1005. PubMed ID: 25468570
[TBL] [Abstract][Full Text] [Related]
6. Roles of TRAF3 in T cells: many surprises.
Yi Z; Wallis AM; Bishop GA
Cell Cycle; 2015; 14(8):1156-63. PubMed ID: 25723057
[TBL] [Abstract][Full Text] [Related]
7. Elevated Choline Kinase α-Mediated Choline Metabolism Supports the Prolonged Survival of TRAF3-Deficient B Lymphocytes.
Gokhale S; Lu W; Zhu S; Liu Y; Hart RP; Rabinowitz JD; Xie P
J Immunol; 2020 Jan; 204(2):459-471. PubMed ID: 31826940
[TBL] [Abstract][Full Text] [Related]
8. Dysregulated TRAF3 and BCL2 Expression Promotes Multiple Classes of Mature Non-hodgkin B Cell Lymphoma in Mice.
Perez-Chacon G; Adrados M; Vallejo-Cremades MT; Lefebvre S; Reed JC; Zapata JM
Front Immunol; 2018; 9():3114. PubMed ID: 30687320
[TBL] [Abstract][Full Text] [Related]
9. TRAF3 plays a role in lupus nephritis by regulating Th17 cell and Treg cell balance as well as NF-κB signaling pathway in mice.
Sun XQ; Liu WS; Zhang HM; Xuan CY; Wang Y; Fu BB
Gen Physiol Biophys; 2022 Mar; 41(2):151-158. PubMed ID: 35416178
[TBL] [Abstract][Full Text] [Related]
10. TRAF3 regulates the effector function of regulatory T cells and humoral immune responses.
Chang JH; Hu H; Jin J; Puebla-Osorio N; Xiao Y; Gilbert BE; Brink R; Ullrich SE; Sun SC
J Exp Med; 2014 Jan; 211(1):137-51. PubMed ID: 24378539
[TBL] [Abstract][Full Text] [Related]
11. TRAF3, ubiquitination, and B-lymphocyte regulation.
Lin WW; Hostager BS; Bishop GA
Immunol Rev; 2015 Jul; 266(1):46-55. PubMed ID: 26085206
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial Fission Factor Is a Novel Interacting Protein of the Critical B Cell Survival Regulator TRAF3 in B Lymphocytes.
Liu Y; Gokhale S; Jung J; Zhu S; Luo C; Saha D; Guo JY; Zhang H; Kyin S; Zong WX; White E; Xie P
Front Immunol; 2021; 12():670338. PubMed ID: 34745083
[TBL] [Abstract][Full Text] [Related]
13. Autoimmunity and immunodeficiency associated with monoallelic LIG4 mutations via haploinsufficiency.
Jauch AJ; Bignucolo O; Seki S; Ghraichy M; Delmonte OM; von Niederhäusern V; Higgins R; Ghosh A; Nishizawa M; Tanaka M; Baldrich A; Köppen J; Hirsiger JR; Hupfer R; Ehl S; Rensing-Ehl A; Hopfer H; Prince SS; Daley SR; Marquardsen FA; Meyer BJ; Tamm M; Daikeler TD; Diesch T; Kühne T; Helbling A; Berkemeier C; Heijnen I; Navarini AA; Trück J; de Villartay JP; Oxenius A; Berger CT; Hess C; Notarangelo LD; Yamamoto H; Recher M
J Allergy Clin Immunol; 2023 Aug; 152(2):500-516. PubMed ID: 37004747
[TBL] [Abstract][Full Text] [Related]
14. Myeloid cell TRAF3 regulates immune responses and inhibits inflammation and tumor development in mice.
Lalani AI; Moore CR; Luo C; Kreider BZ; Liu Y; Morse HC; Xie P
J Immunol; 2015 Jan; 194(1):334-48. PubMed ID: 25422508
[TBL] [Abstract][Full Text] [Related]
15. Activation-induced tumor necrosis factor receptor-associated factor 3 (Traf3) alternative splicing controls the noncanonical nuclear factor κB pathway and chemokine expression in human T cells.
Michel M; Wilhelmi I; Schultz AS; Preussner M; Heyd F
J Biol Chem; 2014 May; 289(19):13651-60. PubMed ID: 24671418
[TBL] [Abstract][Full Text] [Related]
16. Proteomic profiling of the TRAF3 interactome network reveals a new role for the ER-to-Golgi transport compartments in innate immunity.
van Zuylen WJ; Doyon P; Clément JF; Khan KA; D'Ambrosio LM; Dô F; St-Amant-Verret M; Wissanji T; Emery G; Gingras AC; Meloche S; Servant MJ
PLoS Pathog; 2012; 8(7):e1002747. PubMed ID: 22792062
[TBL] [Abstract][Full Text] [Related]
17. The TRAF3 adaptor protein drives proliferation of anaplastic large cell lymphoma cells by regulating multiple signaling pathways.
Muro I; Fang G; Gardella KA; Mahajan IM; Wright CW
Cell Cycle; 2014; 13(12):1918-27. PubMed ID: 24739416
[TBL] [Abstract][Full Text] [Related]
18. Rescue of TRAF3-null mice by p100 NF-kappa B deficiency.
He JQ; Zarnegar B; Oganesyan G; Saha SK; Yamazaki S; Doyle SE; Dempsey PW; Cheng G
J Exp Med; 2006 Oct; 203(11):2413-8. PubMed ID: 17015635
[TBL] [Abstract][Full Text] [Related]
19. Neuron-Specific Tumor Necrosis Factor Receptor-Associated Factor 3 Is a Central Regulator of Neuronal Death in Acute Ischemic Stroke.
Gong J; Li ZZ; Guo S; Zhang XJ; Zhang P; Zhao GN; Gao L; Zhang Y; Zheng A; Zhang XF; Xiang M; Li H
Hypertension; 2015 Sep; 66(3):604-16. PubMed ID: 26269654
[TBL] [Abstract][Full Text] [Related]
20. Roles of tumor necrosis factor receptor associated factor 3 (TRAF3) and TRAF5 in immune cell functions.
Hildebrand JM; Yi Z; Buchta CM; Poovassery J; Stunz LL; Bishop GA
Immunol Rev; 2011 Nov; 244(1):55-74. PubMed ID: 22017431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
